Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| SNCTP000005396 | Registry Identifier | Swiss National Clinical Trials Portal |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| ETH Zurich | OTHER |
| University of St.Gallen | OTHER |
Not provided
Not provided
Not provided
Not provided
To analyze driving behavior of individuals under the influence of alcohol while driving in a real car. Based on the in-vehicle variables, the investigators aim at establishing algorithms capable of discriminating sober and drunk driving using machine learning.
Driving under the influence of alcohol (or "drunk driving") is one of the most significant causes of traffic accidents. Alcohol consumption impairs neurocognitive and psychomotor function and has been shown to be associated with an increased risk of driving accidents. However, autonomous driving (level 4 or 5) is likely to be broadly available only at a substantially later time point than previously thought due to increasing concerns of safety associated with this technology. Therefore, solutions bridging the upcoming time period by more rapidly and directly addressing the problem of drunk driving associated traffic incidents are urgently needed.
On the supposition that driving behavior differs significantly between sober state and drunk state, the investigators assume that different driving patterns of people under alcohol influence compared to sober states can be used to generate drunk driving detection models using machine learning algorithms. In this study, driving for data collection is initially performed at a sober baseline state (no alcohol) and then after alcohol administration (with a target of 0.15 mg/l and 0.35 mg/l breath alcohol concentration).
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Treatment Group | Experimental | Driving under the influence of alcohol Aware of the possible induction of alcohol (purpose of the study), but blinded to the actual amount and target blood alcohol concentration |
|
| Reference Group | No Intervention | Driving without the influence of alcohol or placebo Fully informed | |
| Placebo Group | Placebo Comparator | Driving under the influence of a placebo Not informed (blinded) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Driving under the influence of alcohol | Other | Participants will drive in three different states (sober, drunk above and below the legal limit) on a designated circuit with a real car on a test track accompanied by a driving instructor. After the initial sober driving session, participants are administered pre-mixed alcoholic beverages (e.g., vodka orange). Participants are expected to achieve a target breath alcohol concentration of 0.35 mg/l (legal limit in Switzerland is 0.25 mg/l breath alcohol concentration) before the second driving session starts. Finally, the third driving session starts when the participants' breath alcohol concentration drops to 0.15 mg/l. Participants will be blinded to their alcohol levels during the study. Measurements: Heart rate, respiration rate, blood oxygen saturation, skin conductance, skin temperature, accelerometer, eye movement, radar, facial expression, audio recording, vehicle data, in-cabin gas concentration |
| Measure | Description | Time Frame |
|---|---|---|
| Diagnostic accuracy of the drunk driving warning system (DRIVE) to detect states of alcohol influence while driving quantified as the Area Under the Receiver Operator Characteristics Curve (AUROC) | The machine learning model is developed and evaluated based on in-vehicle data generated in different states of alcohol intoxication. Detection performance of alcohol influence is quantified as AUROC. | 480 minutes |
| Measure | Description | Time Frame |
|---|---|---|
| Diagnostic accuracy of the drunk driving warning system using physiological data to detect states of alcohol influence quantified as the Area Under the Receiver Operator Characteristics Curve (AUROC) | The machine learning model is developed and evaluated based on physiological wearable data recorded in different states of alcohol intoxication. Detection performance of alcohol influence is quantified as AUROC. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Wolfgang Weinmann, Prof. Dr. | University of Bern | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Institut für Rechtsmedizin | Bern | 3008 | Switzerland |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000066448 | Driving Under the Influence |
| D000428 | Alcohol Drinking |
| D056733 | Carney Complex |
| ID | Term |
|---|---|
| D000066479 | Criminal Behavior |
| D001519 | Behavior |
| D003617 | Dangerous Behavior |
| D004327 | Drinking Behavior |
Not provided
Not provided
| ID | Term |
|---|---|
| D000431 | Ethanol |
| ID | Term |
|---|---|
| D000438 | Alcohols |
| D009930 | Organic Chemicals |
Not provided
Not provided
Treatment group (32 participants); Reference group (12 participants); Placebo group (12 participants)
Not provided
Not provided
The participants of the treatment group are aware of the possible induction of alcohol (purpose of the study), but blinded to the actual amount and target blood alcohol concentration. The participants of the reference group are fully informed that they do not get alcohol (open-label). The participants of the placebo group are not informed that they do not get alcohol but a placebo (blinded).
|
| Driving under the influence of a placebo | Other | Participants will drive three times at the same intervals as the treatment group on a designated circuit with a real car on a test track accompanied by a driving instructor. After the initial driving session, participants receive placebo beverages (e.g., orange juice with vodka flavor). Participants are fully blinded. Measurements: Heart rate, respiration rate, blood oxygen saturation, skin conductance, skin temperature, accelerometer, eye movement, radar, facial expression, audio recording, vehicle data, in-cabin gas concentration |
|
| 480 minutes |
| Diagnostic accuracy of the drunk driving warning system using eye-tracking data to detect states of alcohol influence quantified as the AUROC | The machine learning model is developed and evaluated based on eye-tracking data recorded in different states of alcohol intoxication. Detection performance of alcohol influence is quantified as AUROC. | 480 minutes |
| Diagnostic accuracy of the drunk driving warning system using controller area network data of the study car to detect states of alcohol influence quantified as the AUROC | The machine learning model is developed and evaluated based on controller area network data of the study car recorded in different states of alcohol intoxication. Detection performance of alcohol influence is quantified as AUROC. | 480 minutes |
| Diagnostic accuracy of the drunk driving warning system using audio data to detect states of alcohol influence quantified as the AUROC | The machine learning model is developed and evaluated based on audio data recorded in different states of alcohol intoxication. Detection performance of alcohol influence is quantified as AUROC. | 480 minutes |
| Diagnostic accuracy of the drunk driving warning system using radar sensor data to detect states of alcohol influence quantified as the AUROC | The machine learning model is developed and evaluated based on radar sensor data recorded in different states of alcohol intoxication. Detection performance of alcohol influence is quantified as AUROC. | 480 minutes |
| Diagnostic accuracy of the drunk driving warning system using gas sensor data to detect states of alcohol influence quantified as the AUROC | The machine learning model is developed and evaluated based on gas sensor data recorded in different states of alcohol intoxication. Detection performance of alcohol influence is quantified as AUROC. | 480 minutes |
| Change of steering over the alcohol intoxication trajectory | Steering is recorded based on the controller area network. | 480 minutes |
| Change of steer torque over the alcohol intoxication trajectory | Steer torque is recorded based on the controller area network. | 480 minutes |
| Change of steer speed over the alcohol intoxication trajectory | Steer speed is recorded based on the controller area network. | 480 minutes |
| Change of velocity over the alcohol intoxication trajectory | Velocity is recorded based on the controller area network. | 480 minutes |
| Change of acceleration over the alcohol intoxication trajectory | Acceleration is recorded based on the controller area network. | 480 minutes |
| Change of braking over the alcohol intoxication trajectory | Braking is recorded based on the controller area network. | 480 minutes |
| Change of swerving over the alcohol intoxication trajectory | Swerving is recorded based on the controller area network. | 480 minutes |
| Change of spinning over the alcohol intoxication trajectory | Spinning is recorded based on the controller area network. | 480 minutes |
| Change of gaze position over the alcohol intoxication trajectory | Gaze position is recorded using an eye-tracker device. | 480 minutes |
| Change of gaze velocity over the alcohol intoxication trajectory | Gaze velocity is recorded using an eye-tracker device. | 480 minutes |
| Change of gaze acceleration over the alcohol intoxication trajectory | Gaze acceleration is recorded using an eye-tracker device. | 480 minutes |
| Change of gaze regions of interest over the alcohol intoxication trajectory | Gaze regions of interest (e.g., windshield, car dashboard, etc.) are recorded using an eye-tracker device. | 480 minutes |
| Change of gaze events over the alcohol intoxication trajectory | Gaze events (e.g., fixations, saccades, etc.) are recorded using an eye-tracker device. | 480 minutes |
| Change of head pose over the alcohol intoxication trajectory | Head pose (position/rotation) is recorded using an eye-tracker device. | 480 minutes |
| Change of heart rate over the alcohol intoxication trajectory | Heart rate is recorded using a heart rate monitoring device and wearables. | 480 minutes |
| Change of heart rate variability over the alcohol intoxication trajectory | Heart rate variability is recorded using a heart rate monitoring device and wearables. | 480 minutes |
| Change of electrodermal activity over the alcohol intoxication trajectory | Electrodermal activity is recorded using wearables. | 480 minutes |
| Change of wrist accelerometer measurements over the alcohol intoxication trajectory | Wrist accelerometer measurements are recorded using wearables. | 480 minutes |
| Change of skin temperature over the alcohol intoxication trajectory | Skin temperature is recorded using wearables. | 480 minutes |
| Self-assessment of driving performance over the alcohol intoxication trajectory | Participants rate their driving performance on a 7-point Likert Scale (lower value means poorer driving performance). | 480 minutes |
| Self-estimation of alcohol concentrations over the alcohol intoxication trajectory | Participants estimate their blood alcohol concentration. | 480 minutes |
| Number of driving mishaps over the alcohol intoxication trajectory | Any driving mishaps, accidents and interventions by the driving instructor will be documented. | 480 minutes |
| Number of Adverse Events (AEs) | Adverse Events will be recorded at each study visit. | 3 months, from screening to close out visit for each participant |
| Number of Serious Adverse Events (SAEs) | Serious Adverse Events will be recorded at each study visit. | 3 months, from screening to close out visit for each participant. |
| D009232 |
| Myxoma |
| D009372 | Neoplasms, Connective Tissue |
| D018204 | Neoplasms, Connective and Soft Tissue |
| D009370 | Neoplasms by Histologic Type |
| D009369 | Neoplasms |
| D006338 | Heart Neoplasms |
| D013899 | Thoracic Neoplasms |
| D009371 | Neoplasms by Site |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D000015 | Abnormalities, Multiple |
| D000013 | Congenital Abnormalities |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| D012868 | Skin Abnormalities |